A medical journal article published by the Journal of the American College of Cardiology in October 2018 reports that Imbruvica cardiovascular adverse drug reactions often occurred soon after the administration of Imbruvica. In summary, patients treated with Imbruvica had an increased occurrence … More
Main Navigation Menu
➤ Pharmaceutical Drug Injury Lawsuits
➤ Asbestos and Mesothelioma Claims
➤ Benzene Diseases and Cancers Claims
➤ GenX Water Contamination Cancer Cases
➤ Breast Implants Lymphoma Cancer Cases
➤ Free Case Evaluation by Lawyer Tom Lamb
➤ About the Law Offices of Thomas J. Lamb
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Collection of Articles by Our Law Firm
Please know that you can use our Quick Contact Form to tell us a bit about your case.
Recent Articles
Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial
Objectives: Intracavitary chemotherapy is a promising concept to improve local tumor control for malignant pleural mesothelioma with reported high morbidity rates. We have demonstrated that administration of cisplatin loaded to fibrin increased local drug concentration and reduced systemic toxicity … More
Lemtrada Adverse Events: Ten Deaths Related To Lemtrada, According To New Medical Journal Article
Lemtrada adverse events (AEs) may occur more frequently than previously understood, according to an August 2019 medical journal article. This new Lemtrada drug safety information appeared in this article, “Adverse events with fatal outcome associated with alemtuzumab treatment in multiple … More
Owkin’s mesothelioma AI discovers new biomarkers from lung biopsy images
By scanning thousands of tissue samples, [ Owkin’s mesothelioma AI program ] was able to help identify new types of patients with mesothelioma and predict which may respond better to certain therapies. Using whole biopsy slide images taken from nearly 3,000 patients with the aggressive and … More
Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy
Patients with mesothelioma may gain similar benefit from immunotherapy as chemotherapy, and good responders may provide important clues to novel treatment for the thousands of new cases each year. Data from the PROMISE-meso trial presented at the ESMO Congress 2019 highlight the need to understand … More
Aricept: Rhabdomyolysis Is A Side Effect For This Alzheimer’s Drug
There is a risk of the muscle injury rhabdomyolysis with Aricept (donepezil), a drug commonly used to manage cognitive decline in Alzheimer’s patients. This is according to a recent study published online by CMAJ (Canadian Medical Association Journal), “Risk of rhabdomyolysis with donepezil … More